Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders

Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders

Lewy Body Disorders (LBDs) lie within the spectrum of age-related neurodegenerative diseases now frequently categorized as the synucleinopathies. LBDs are considered to be among the second most common form of neurodegenerative dementias after Alzheimer's disease. They are progressive conditions...

Full description

Bibliographic Details
Main Authors:	Nelson de Oliveira Manzanza, Lucia Sedlackova, Raj N. Kalaria
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-06-01
Series:	Frontiers in Aging Neuroscience
Subjects:	alpha synuclein neuronal membrane Lewy body disorders post-translational modifications dementia
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2021.690293/full

Similar Items

Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies
by: Attems, J., et al.
Published: (2022)

Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies
by: Connor Bargar, et al.
Published: (2021-04-01)

Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies
by: Christopher Hatton, et al.
Published: (2020-07-01)

Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
by: Allison J. Schaser, et al.
Published: (2020-08-01)

Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer’s disease and dementia with Lewy bodies from the prodromal stage
by: Olivier Bousiges, et al.
Published: (2020-09-01)

Dementia with Lewy bodies: an update and outlook
by: Tiago Fleming Outeiro, et al.
Published: (2019-01-01)

Studies of α-synuclein Oligomers-with Relevance to Lewy Body Disorders
by: Fagerqvist, Therese
Published: (2013)

Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro
by: Janett Köppen, et al.
Published: (2020-01-01)

Alpha-synuclein oligomers - neurotoxic molecules in Parkinson’s disease and other Lewy body disorders
by: Martin Ingelsson
Published: (2016-09-01)

Proteolytic α-Synuclein Cleavage in Health and Disease
by: Alexandra Bluhm, et al.
Published: (2021-05-01)

Alpha-Synuclein Pathology Coincides With Increased Number of Early Stage Neural Progenitors in the Adult Hippocampus
by: Hannah Bender, et al.
Published: (2021-07-01)

The Roles of Post-translational Modifications on α-Synuclein in the Pathogenesis of Parkinson’s Diseases
by: Jiaming Zhang, et al.
Published: (2019-04-01)

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
by: Naomi P. Visanji, et al.
Published: (2019-09-01)

Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson’s Disease
by: Laura Marsal-García, et al.
Published: (2021-01-01)

A method of purifying alpha-synuclein in E. coli without chromatography
by: Sumaer Kamboj, et al.
Published: (2021-01-01)

Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
by: P.G. Foulds, et al.
Published: (2012-01-01)

Alpha-Synuclein Physiology and Pathology: A Perspective on Cellular Structures and Organelles
by: Luis D. Bernal-Conde, et al.
Published: (2020-01-01)

The Role of Neutral Sphingolipids in the Pathogenesis of Parkinson Disease and Dementia with Lewy Bodies
by: Singh, Priyanka
Published: (2013)

The Role of Neutral Sphingolipids in the Pathogenesis of Parkinson Disease and Dementia with Lewy Bodies
by: Singh, Priyanka
Published: (2013)

14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model
by: Rachel Underwood, et al.
Published: (2021-01-01)

Advancing Stem Cell Models of Alpha-Synuclein Gene Regulation in Neurodegenerative Disease
by: Desiree A. Piper, et al.
Published: (2018-04-01)

Alpha-synuclein aggresomes inhibit ciliogenesis and multiple functions of the centrosome
by: Anila Iqbal, et al.
Published: (2020-10-01)

Brain-derived exosomes from dementia with Lewy bodies propagate α-synuclein pathology
by: Jennifer Ngolab, et al.
Published: (2017-06-01)

Effects of α-synuclein on axonal transport
by: Laura A. Volpicelli-Daley
Published: (2017-09-01)

Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions
by: Lindsay E. Stoyka, et al.
Published: (2020-02-01)

GBA-Associated Synucleinopathies: Prime Candidates for Alpha-Synuclein Targeting Compounds
by: Kathrin Brockmann, et al.
Published: (2020-09-01)

Role of Alterations in Protein Kinase p38γ in the Pathogenesis of the Synaptic Pathology in Dementia With Lewy Bodies and α-Synuclein Transgenic Models
by: Michiyo Iba, et al.
Published: (2020-03-01)

Patient-Derived Induced Pluripotent Stem Cells and Organoids for Modeling Alpha Synuclein Propagation in Parkinson's Disease
by: Yong Hui Koh, et al.
Published: (2018-11-01)

Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers
by: Tomohiro Umeda, et al.
Published: (2021-08-01)

Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF
by: Walter A. Boiten, et al.
Published: (2021-12-01)

Rapid Alpha-Synuclein Toxicity in a Neural Cell Model and Its Rescue by a Stearoyl-CoA Desaturase Inhibitor
by: Elizabeth Terry-Kantor, et al.
Published: (2020-07-01)

Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagation
by: Christopher Mezias, et al.
Published: (2020-02-01)

Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression
by: Zachary A. Sorrentino, et al.
Published: (2019-09-01)

Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models
by: Michiyo Iba, et al.
Published: (2020-07-01)

The Membrane Interaction of Alpha-Synuclein
by: Cencen Liu, et al.
Published: (2021-03-01)

Possible Alterations in β-Synuclein, the Non-Amyloidogenic Homologue of α-Synuclein, during Progression of Sporadic α-Synucleinopathies
by: Makoto Hashimoto, et al.
Published: (2012-09-01)

Parkinson’s Disease Dementia and Dementia with Lewy Bodies Have Similar Neuropsychological Profiles
by: Georgina M. Aldridge, et al.
Published: (2018-03-01)

Cathepsin Oxidation Alters Alpha-Synuclein Processing
by: Andrew W. Ferree
Published: (2019-05-01)

Colonic inflammation affects myenteric alpha-synuclein in nonhuman primates
by: Resnikoff H, et al.
Published: (2019-05-01)

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
by: Puyu Li, et al.
Published: (2021-10-01)